- Home
- CPZ vs OSUR Comparison
CPZ vs OSUR Comparison
Compare CPZ & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPZ
- OSUR
- Stock Information
- Founded
- CPZ 2019
- OSUR 2000
- Country
- CPZ United States
- OSUR United States
- Employees
- CPZ N/A
- OSUR N/A
- Industry
- CPZ Trusts Except Educational Religious and Charitable
- OSUR Medical/Dental Instruments
- Sector
- CPZ Finance
- OSUR Health Care
- Exchange
- CPZ Nasdaq
- OSUR Nasdaq
- Market Cap
- CPZ 300.2M
- OSUR 284.9M
- IPO Year
- CPZ N/A
- OSUR 1986
- Fundamental
- Price
- CPZ $15.27
- OSUR $3.80
- Analyst Decision
- CPZ
- OSUR Hold
- Analyst Count
- CPZ 0
- OSUR 2
- Target Price
- CPZ N/A
- OSUR $5.50
- AVG Volume (30 Days)
- CPZ 63.0K
- OSUR 821.4K
- Earning Date
- CPZ 01-01-0001
- OSUR 02-25-2025
- Dividend Yield
- CPZ 11.07%
- OSUR N/A
- EPS Growth
- CPZ N/A
- OSUR N/A
- EPS
- CPZ N/A
- OSUR 0.15
- Revenue
- CPZ N/A
- OSUR $224,263,000.00
- Revenue This Year
- CPZ N/A
- OSUR N/A
- Revenue Next Year
- CPZ N/A
- OSUR N/A
- P/E Ratio
- CPZ N/A
- OSUR $25.16
- Revenue Growth
- CPZ N/A
- OSUR N/A
- 52 Week Low
- CPZ $13.17
- OSUR $3.52
- 52 Week High
- CPZ $16.11
- OSUR $8.04
- Technical
- Relative Strength Index (RSI)
- CPZ 42.44
- OSUR 45.88
- Support Level
- CPZ $15.13
- OSUR $3.73
- Resistance Level
- CPZ $15.56
- OSUR $4.01
- Average True Range (ATR)
- CPZ 0.14
- OSUR 0.11
- MACD
- CPZ -0.04
- OSUR -0.01
- Stochastic Oscillator
- CPZ 21.21
- OSUR 21.21
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.